November 5, 2025 — Leads & Copy — Vistagen (Nasdaq: VTGN) CEO Shawn Singh will participate in a fireside chat at the Stifel Healthcare Conference on Wednesday, November 12, from 3:20-3:50 p.m. Eastern Time. The company will also host one-on-one meetings during the conference. A live webcast will be accessible through the “Events” page in the “Investors” section of Vistagen’s website.
Vistagen, headquartered in South San Francisco, CA, is a late clinical-stage biopharmaceutical company developing intranasal product candidates called pherines, designed to rapidly trigger olfactory bulb-to-brain neurocircuits believed to regulate brain areas involved in behavior and autonomic nervous system activity.
Vistagen is focused on creating transformative treatment options to improve the lives of individuals underserved by the current standard of care for multiple highly prevalent indications, including social anxiety disorder, major depressive disorder, vasomotor symptoms (hot flashes) associated with menopause, and premenstrual dysphoric disorder.
Source: Vistagen
